Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год
Применить Всего найдено 14. Отображено 14.
24-05-2018 дата публикации

ANTIBODY SPECIFICALLY BINDING TO CD66C AND USE THEREOF

Номер: KR1020180054492A
Автор: YOON, SANG SOON, HONG, KWON PYO, KIM, SOS EUL, JI, GIL YONG, LIM, YOUNG HOON
Принадлежит:

The present invention relates to an anti-CD66c antibody and a use thereof for treating cancer. Specifically, the present invention relates to an antibody which recognizes and binds to CD66c and is capable of inducing T-cell activation or a humoral immune response by using the antibody specifically recognizing CD66c. The present invention further relates to a nucleic acid molecule encoding the antibody or an antigen binding fragment, a vector comprising the nucleic acid molecule, a host cell, and a use of the antibody or the antigen binding fragment for alleviating, preventing, treating, or diagnosing CD66c-related disease such as solid cancer. COPYRIGHT KIPO 2018 ...

Подробнее
Номер записи: 1
12-07-2018 дата публикации

ANTI-CEACAM6 CHIMERIC ANTIGEN RECEPTOR SPECIFICALLY BINDING TO CEACAM6

Номер: WO2018128486A1
Автор: CHOI, In Pyo, KIM, Tae-Don, SEO, Hui Yun, LEE, Sooyun, HONG, Kwon Pyo
Принадлежит:

The present invention relates to an anti-CEACAM6 chimeric antigen receptor (CAR) specifically binding to CEACAM6, and a cell therapeutic agent comprising same. The chimeric antigen receptor according to the present invention is characterized by specifically binding to CEACAM6 and can be a useful target for a targeted anticancer agent. Accordingly, the chimeric antigen receptor according to the present invention can induce immunocytes to move effectively to tumor tissue and be usefully employed in a gene and cell therapy exhibiting highly efficient anticancer effects.

Подробнее
Номер записи: 2
17-05-2018 дата публикации

ANTIBODY BINDING SPECIFICALLY TO CD66C AND USE THEREOF

Номер: WO2018088877A2
Автор: YOON, Sangsoon, HONG, Kwon Pyo, KIM, Soseul, JI, Gil Yong, LIM, Young Hoon
Принадлежит:

The present invention relates to an anti-CD66c antibody and a use thereof for cancer treatment and, particularly, to an antibody that can induce T-cell activation or the humoral immune response by using the antibody specifically recognizing CD66c, and recognize and bind to CD66c; a nucleic acid molecule encoding the antibody or an antigen-binding fragment; a vector and a host cell comprising the nucleic acid molecule; and a use of the antibody or the antigen-binding fragment for alleviation, prevention, treatment, or diagnosis of CD66c related diseases, for example, solid cancer.

Подробнее
Номер записи: 3
26-07-2018 дата публикации

ANTIBODY BINDING SPECIFICALLY TO CD40 AND USE THEREOF

Номер: WO2018088850A3
Автор: JI, Gil Yong, HONG, Kwon Pyo, LEE, Eui Sup, MOON, Yoo Ri, YOON, Sangsoon
Принадлежит:

The present invention relates to an anti-CD40 antibody binding specifically to CD40 and use thereof and, particularly, provides an anti-CD40 antibody or an antigen-binding fragment thereof, and a pharmaceutical composition comprising the same antibody or fragment as an effective ingredient for prevention and/or treatment of cancer, cancer metastasis, infection, and/or immune deficiency diseases.

Подробнее
Номер записи: 4
25-09-2017 дата публикации

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING LUNG CANCER COMPRISING ANTIBODY AGAINST CD66c AND CHEMICAL DRUG

Номер: KR1020170107325A
Автор: HONG, KWON PYO, SHIN, MI HYANG, YOON, SANG SOON, JEE, GIL YONG, MOON, YU RI
Принадлежит:

The present invention relates to uses for preventing or treating lung cancer through combination therapy of an antibody recognizing CD66c epitope specific to lung adenocarcinoma or antigen-binding fragments thereof and a chemical anticancer agent. COPYRIGHT KIPO 2017 ...

Подробнее
Номер записи: 5
08-11-2018 дата публикации

ANTIBODY BINDING SPECIFICALLY TO CD66C AND USE THEREOF

Номер: WO2018088877A9
Автор: YOON, Sangsoon, HONG, Kwon Pyo, KIM, Soseul, JI, Gil Yong, LIM, Young Hoon
Принадлежит:

The present invention relates to an anti-CD66c antibody and a use thereof for cancer treatment and, particularly, to an antibody that can induce T-cell activation or the humoral immune response by using the antibody specifically recognizing CD66c, and recognize and bind to CD66c; a nucleic acid molecule encoding the antibody or an antigen-binding fragment; a vector and a host cell comprising the nucleic acid molecule; and a use of the antibody or the antigen-binding fragment for alleviation, prevention, treatment, or diagnosis of CD66c related diseases, for example, solid cancer.

Подробнее
Номер записи: 6
13-07-2018 дата публикации

ANTI-CEACAM6 CHIMERIC ANTIGEN RECEPTOR SPECIFICALLY BINDING TO CEACAM6

Номер: KR1020180081011A
Автор: CHOI IN PYO, KIM TAE DON, SEO HUI YUN, LEE SOO YUN, HONG KWON PYO
Принадлежит:

The present invention relates to an anti-CEACAM6 chimeric antigen receptor (CAR) specifically binding to CEACAM6, and to a cell therapeutic agent comprising the same. The CAR according to the present invention is characterized by specifically binding to CEACAM6 and can be a useful target for a targeted anticancer agent. Accordingly, the CAR according to the present invention can induce immunocytes to move effectively to tumor tissue and be usefully employed in a gene and cell therapy exhibiting highly efficient anticancer effects. COPYRIGHT KIPO 2018 ...

Подробнее
Номер записи: 7
20-04-2017 дата публикации

ANTI-CD43 ANTIBODY AND USE THEREOF FOR CANCER TREATMENT

Номер: WO2017065493A8
Автор: HONG, Kwon Pyo, YOON, Sangsoon, KOUKOULAS, Irene, BATORI, Vincent, CRISTIANO, Briony, WILSON JR, David S, KOPSIDAS, George
Принадлежит:

The present invention relates to an antibody for cancer treatment and provides an anti-CD43 antibody which binds an extracellular region of CD43, an anti-cancer composition and a composition for inhibiting cancer stem cells comprising the anti-CD43 antibody as an active ingredient, and a method for screening a cancer stem cell inhibitor.

Подробнее
Номер записи: 8
21-05-2018 дата публикации

ANTIBODY SPECIFICALLY BINDING TO CD40 AND USE THEREOF

Номер: KR1020180053255A
Автор: JI, GIL YONG, HONG, KWON PYO, LEE, EUI SUP, MOON, YOO RI, YOON, SANG SOON
Принадлежит:

The present invention relates to an antibody specifically binding to CD40 and a use thereof, Specifically, the present invention provides a pharmaceutical composition for preventing and/or treating cancer, metastasis, infection, and/or immunodeficiency diseases which containing an anti-CD40 antibody or an antigen-binding fragment thereof as an effective component. COPYRIGHT KIPO 2018 ...

Подробнее
Номер записи: 9
10-10-2017 дата публикации

ＣＤ66ｃ에 대한 항체와 화학치료제를 포함하는 폐암 예방 또는 치료용 약학조성물

Номер: KR0101783907B1
Автор: 홍권표, 신미향, 윤상순, 지길용, 문유리
Принадлежит: 다이노나(주)

... 본 발명은 CD66c의 폐선암 특이적 에피토프를 인식하는 항체 또는 이의 항원 결합 단편과 화학 항암제를 병용하여 폐암 예방 또는 치료 용도에 대한 것이다.

Подробнее
Номер записи: 10
04-10-2018 дата публикации

ANTIBODY BINDING SPECIFICALLY TO CD66C AND USE THEREOF

Номер: WO2018088877A3
Автор: YOON, Sangsoon, HONG, Kwon Pyo, KIM, Soseul, JI, Gil Yong, LIM, Young Hoon
Принадлежит:

The present invention relates to an anti-CD66c antibody and a use thereof for cancer treatment and, particularly, to an antibody that can induce T-cell activation or the humoral immune response by using the antibody specifically recognizing CD66c, and recognize and bind to CD66c; a nucleic acid molecule encoding the antibody or an antigen-binding fragment; a vector and a host cell comprising the nucleic acid molecule; and a use of the antibody or the antigen-binding fragment for alleviation, prevention, treatment, or diagnosis of CD66c related diseases, for example, solid cancer.

Подробнее
Номер записи: 11
17-05-2018 дата публикации

ANTIBODY BINDING SPECIFICALLY TO CD40 AND USE THEREOF

Номер: WO2018088850A2
Автор: JI, Gil Yong, HONG, Kwon Pyo, LEE, Eui Sup, MOON, Yoo Ri, YOON, Sangsoon
Принадлежит:

The present invention relates to an anti-CD40 antibody binding specifically to CD40 and use thereof and, particularly, provides an anti-CD40 antibody or an antigen-binding fragment thereof, and a pharmaceutical composition comprising the same antibody or fragment as an effective ingredient for prevention and/or treatment of cancer, cancer metastasis, infection, and/or immune deficiency diseases.

Подробнее
Номер записи: 12
20-04-2017 дата публикации

ANTI-CD43 ANTIBODY AND USE THEREOF FOR CANCER TREATMENT

Номер: WO2017065493A1
Автор: HONG, Kwon Pyo, YOON, Sangsoon, KOUKOULAS, Irene, CRISTIANO, Briony, WILSON JR, David S, KOPSIDAS, George
Принадлежит:

The present invention relates to an antibody for cancer treatment and provides an anti-CD43 antibody which binds an extracellular region of CD43, an anti-cancer composition and a composition for inhibiting cancer stem cells comprising the anti-CD43 antibody as an active ingredient, and a method for screening a cancer stem cell inhibitor.

Подробнее
Номер записи: 13
20-07-2018 дата публикации

Anti - CD43 antibodies and use the treatment of cancer

Номер: KR1020180083315A
Автор: HONG KWON PYO, YOON SANGSOON, KOUKOULAS IRENE, BATORI VINCENT, CRISTIANO BRIONY, WILSON JR DAVID S, KOPSIDAS GEORGE
Принадлежит:

... 암 치료용 항체에 관한 것으로, CD43의 세포외 영역에 결합하는 항-CD43 항체, 이를 유효성분으로 포함하는 항암 조성물, 암줄기세포 저해용 조성물, 및 암줄기세포 저해제의 스크리닝 방법이 제공된다.

Подробнее
Номер записи: 14